GR1014-CG 2.4% clinical trials

A Study of GR1014 Cutaneous Gel for the Prevention of Skin Reactions Caused by Radiation Therapy for Breast Cancer

This study tests a new gel, GR1014-CG, to see if it can prevent skin irritation from radiation therapy for breast cancer. Women over 18, who have had breast surgery and need radiation, can join. It checks if the gel is safe and helps reduce redness or soreness.